Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 5/3074% above fair value
$6.63+0.51 (+8.33%)
Close on Nov 12, 2026Market cap $99.34MP/E –Yield –
Cumberland Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Cumberland Pharmaceuticals's cash was $3.86M at Jun 30, 2026. For fiscal 2025 it was $11.44M, down 36.3% from the year before. Over ten years it grew -14.2% a year on average. The highest annual figure on record is $78.70M in fiscal 2009.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.44M | -36.3% |
| FY2024 | Dec 31, 2024 | $17.96M | -2.0% |
| FY2023 | Dec 31, 2023 | $18.32M | -7.3% |
| FY2022 | Dec 31, 2022 | $19.76M | -26.9% |
| FY2021 | Dec 31, 2021 | $27.04M | +9.2% |
| FY2020 | Dec 31, 2020 | $24.75M | -12.3% |
| FY2019 | Dec 31, 2019 | $28.21M | -22.1% |
| FY2018 | Dec 31, 2018 | $36.23M | -27.7% |
| FY2017 | Dec 31, 2017 | $50.09M | -0.1% |
| FY2016 | Dec 31, 2016 | $50.13M | -5.0% |
| FY2015 | Dec 31, 2015 | $52.77M | -3.5% |
| FY2014 | Dec 31, 2014 | $54.71M | -0.3% |
| FY2013 | Dec 31, 2013 | $54.89M | -22.7% |
| FY2012 | Dec 31, 2012 | $71.04M | +0.6% |
| FY2011 | Dec 31, 2011 | $70.60M | +7.1% |
| FY2010 | Dec 31, 2010 | $65.89M | -16.3% |
| FY2009 | Dec 31, 2009 | $78.70M | +565.3% |
| FY2008 | Dec 31, 2008 | $11.83M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.86M | -76.0% |
| Q1 FY2026 | Mar 31, 2026 | $11.01M | -27.1% |
| Q4 FY2025 | Dec 31, 2025 | $11.44M | -36.3% |
| Q3 FY2025 | Sep 30, 2025 | $15.20M | -13.0% |
| Q2 FY2025 | Jun 30, 2025 | $16.09M | -7.2% |
| Q1 FY2025 | Mar 31, 2025 | $15.11M | -18.5% |
| Q4 FY2024 | Dec 31, 2024 | $17.96M | -2.0% |
| Q3 FY2024 | Sep 30, 2024 | $17.46M | -5.6% |
| Q2 FY2024 | Jun 30, 2024 | $17.34M | -5.0% |
| Q1 FY2024 | Mar 31, 2024 | $18.55M | +13.2% |
| Q4 FY2023 | Dec 31, 2023 | $18.32M | -7.3% |
| Q3 FY2023 | Sep 30, 2023 | $18.51M | -5.3% |
| Q2 FY2023 | Jun 30, 2023 | $18.25M | +0.2% |
| Q1 FY2023 | Mar 31, 2023 | $16.39M | -5.1% |
| Q4 FY2022 | Dec 31, 2022 | $19.76M | -26.9% |
| Q3 FY2022 | Sep 30, 2022 | $19.54M | -24.4% |
| Q2 FY2022 | Jun 30, 2022 | $18.22M | -29.0% |
| Q1 FY2022 | Mar 31, 2022 | $17.27M | -30.7% |
| Q4 FY2021 | Dec 31, 2021 | $27.04M | +9.2% |
| Q3 FY2021 | Sep 30, 2021 | $25.84M | -3.0% |
| Q2 FY2021 | Jun 30, 2021 | $25.67M | -6.2% |
| Q1 FY2021 | Mar 31, 2021 | $24.92M | -7.8% |
| Q4 FY2020 | Dec 31, 2020 | $24.75M | -12.3% |
| Q3 FY2020 | Sep 30, 2020 | $26.65M | -1.2% |
| Q2 FY2020 | Jun 30, 2020 | $27.37M | +30.7% |
| Q1 FY2020 | Mar 31, 2020 | $27.03M | +9.8% |
| Q4 FY2019 | Dec 31, 2019 | $28.21M | -22.1% |
| Q3 FY2019 | Sep 30, 2019 | $26.98M | -29.5% |
| Q2 FY2019 | Jun 30, 2019 | $20.95M | -41.7% |
| Q1 FY2019 | Mar 31, 2019 | $24.61M | -30.2% |
| Q4 FY2018 | Dec 31, 2018 | $36.23M | -27.7% |
| Q3 FY2018 | Sep 30, 2018 | $38.26M | -8.9% |
| Q2 FY2018 | Jun 30, 2018 | $35.91M | +3.7% |
| Q1 FY2018 | Mar 31, 2018 | $35.26M | +0.8% |
| Q4 FY2017 | Dec 31, 2017 | $50.09M | -0.1% |
| Q3 FY2017 | Sep 30, 2017 | $42.02M | +18.2% |
| Q2 FY2017 | Jun 30, 2017 | $34.62M | – |
| Q1 FY2017 | Mar 31, 2017 | $34.97M | – |
| Q4 FY2016 | Dec 31, 2016 | $50.13M | – |
| Q3 FY2016 | Sep 30, 2016 | $35.55M | – |
See a number that looks wrong?